Allergan urges shareholders to reject Valeant Pharmaceuticals takeover offer
June 23, 2014 - 6:28 AM
MONTREAL - Allergan Inc. urged its shareholders Monday to reject a hostile takeover offer by Valeant Pharmaceuticals International Inc. (TSX:VRX). Valeant, which had tried to negotiate a deal to acquire Allergan, took its offer directly to the company's shareholders last week.
News from © The Canadian Press, 2014